Key result
Altered DNA methylation in COPD basal cells impairs airway epithelial regeneration compared to healthy smokers.
Answers are grounded in this paper and cite their sources.
To gain insight into what biological role the methylation differences might contribute, the methylation data were functionally annotated, using Gene Ontology and the Human Protein Reference Database (www.hprd.org; Figure 2C), with subsequent Ingenuity Pathway Analysis to determine the biological pathways represented in the 75 unique hypermethylated genes and the 202 unique hypomethylated genes.The top pathway represented in the Ingenuity Pathway Analysis of the 75 hypermethylated genes was "cellular growth and proliferation," with 11 molecules represented (BMP7, GRM3, IGFBP7, NPY, RPTOR, MAPK10, HEY1, MGP, PRKCE, MEIS1 , andPRDM16; P , 3 3 10 24 to 5 3 10 22 ).In summary, these data provide ex vivo evidence that SAE basal cells from COPD smokers, and to a lesser extent SAE basal cells from "healthy" smokers, are limited in their ability to regenerate a fully differentiated epithelium.In addition, the methylation studies show that the DNA methylation profile of SAE basal cells that do not survive to Day 28 on ALI culture is significantly different than the profile of SAE basal cells that are able to successfully differentiate, suggesting that changes in DNA methylation acquired by basal cells of COPD smokers and healthy smokers in vivo may be one mechanism for the differences observed.We hypothesize that the lung microenvironment in individuals with COPD provide signals necessary to maintain the "COPD" epigenetic code within SAE basal cells, continuously supporting the disease state by altering the capacity of these stem/progenitor cells to maintain normally differentiated SAE.Therefore, even though the process of DNA methylation is reversible (15), the COPD lung environment might continuously stimulate the COPD DNA methylation profile that may determine abnormal SAE maintenance and regeneration.Thus, it is possible that studies focusing on modulating methylation profiles of SAE basal cells relevant to their capacity to regenerate normally differentiated mucociliary airway epithelium may lead to novel therapeutics to treat or prevent COPD.
No takes yet. Share an insight, caveat, or question.
Gileles‐Hillel et al. (2014) studied COPD. COPD and smoking vs. Healthy smokers was evaluated on DNA methylation profile and capacity to regenerate fully differentiated epithelium ex vivo. Small airway epithelial basal cells from COPD smokers exhibit altered DNA methylation profiles compared to healthy smokers, limiting their ability to regenerate a fully differentiated epithelium.
Synapse has enriched 10 related papers. Consider them for comparative context: